CLOV vs HRMY · rev $1.37B vs P/E 14, rev $714.7M
Clover Health Investments Corp (CLOV) versus Harmony Biosciences Holdings (HRMY) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Harmony Biosciences Holdings (HRMY) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported HRMY revenue for 2024-12-31 was $714.7M. Net income was $145.5M. Revenue was up 22.8% from 2023-12-31 to 2024-12-31. HRMY currently screens at market cap $1.96B and trailing P/E 13.6.
CLOV currently screens at market cap $1.55B. HRMY currently screens at market cap $1.96B and trailing P/E 13.6.
Not investment advice. Open the CLOV and HRMY stock pages for the full models.
Not investment advice.